Skip to content
← Full study record

NCT02112916 · MORE INFO

Limitations, agreements, and source contact

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma · Source last updated 2026-07-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
resultsreportingcoordinator@childrensoncologygroup.org
organization
Children's Oncology Group
phone
16264470064
title
Results Reporting Coordinator
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
resultsreportingcoordinator@childrensoncologygroup.org
organization
Children's Oncology Group
phone
16264470064
title
Results Reporting Coordinator

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice